The CLIC family of proteins display the unique feature of altering their structure from a soluble form to a membrane-bound chloride channel. CLIC1, a member of this family, can be found in the cytoplasm or in nuclear, ER and plasma membranes, with membrane overexpression linked to tumour proliferation. The molecular switch promoting CLIC1 membrane insertion has been related to environmental factors, but still remains unclear. Here, we use solution NMR studies to confirm that both the soluble and membrane bound forms are in the same oxidation state. Our data from fluorescence assays and chloride efflux assays indicate that Ca 2+ and Zn 2+ trigger association to the membrane into active chloride channels. We use fluorescence microscopy to confirm that an increase of the intracellular Ca 2+ leads to re-localisation of CLIC1 to both plasma and internal membranes. Finally, we show that soluble CLIC1 adopts an equilibrium of oligomeric species, and Ca 2+ /Zn 2+ mediated membrane insertion promotes the formation of a tetrameric assembly. Thus, our results identify Ca 2+ and Zn 2+ binding as the molecular switch promoting CLIC1 membrane insertion.
INTRODUCTION
The Chloride Intracellular Channel (CLIC) family consists of a group of highly homologous human proteins with a striking feature, their ability to change their structure upon activation from a soluble form into a membrane bound chloride channel, translocating from the cytoplasm to intracellular membranes (1, 2) . CLIC1 is the best characterised of the CLIC protein family. It is expressed intracellularly in a variety of cell types, being especially abundant in heart and skeletal muscle (2). CLIC1's integral membrane form has been found to be localised mostly in the nuclear membrane, although it is present in the membranes of other organelles and transiently in the plasma membrane. It has also been shown to function as an active chloride channel in phospholipid vesicles when expressed and purified from bacteria, showing clear single channel properties (3, 4) .
CLIC1 has been implicated in the regulation of cell volume, electrical excitability (5), differentiation (6) , cell cycle (7) and cell growth and proliferation (8) . High CLIC1 expression has been reported in a range of malignant tumours, including prostate (9), gastric (10), lung (6) and liver (11) cancers, with evidence of CLIC1 promoting the spread and growth of glioblastoma cancer stem/progenitor cells (12, 13) .
The activity and oncogenic function of CLIC1 is modulated by its equilibrium between the soluble cytosolic form and its membrane bound form. Only CLIC1 in its channel form has been shown to have oncogenic activity, and specific inhibition of the CLIC1 channel halts tumour progression (13) . However, to date very little and conflicting information is available for the membrane insertion mechanism, and the structure of the channel form is unknown. Oxidation with hydrogen peroxide causes a conformational change due to the formation of a disulphide bond between Cys24 and the non-conserved Cys59, exposing a hydrophobic patch that promotes the formation of a dimer (14) , in a process that has been proposed to lead to membrane insertion (15) .
However, numerous studies have shown that oxidation does not promote membrane insertion (16); with evidence pointing at pH (17, 18) or cholesterol (19) as the likely activation factors. Thus, long standing inconsistencies in the data surrounding the molecular switch that unusually transforms CLIC1 from its soluble form into a membrane bound channel has prevented further advances in the understanding of CLIC1 function. In this study, we have explored the membrane insertion mechanism of CLIC1. We used NMR experiments on CLIC1 extracted from the soluble and membrane fraction of E. coli to show that membrane bound CLIC1 is in a reduced state. We demonstrate that CLIC1 exists in an equilibrium between monomers, dimers and higher-order oligomers, and that oligomerisation of CLIC1 is required for membrane insertion. Finally, we use membrane binding assays to show that divalent cations enhance CLIC1 membrane insertion, and fluorescence microscopy and chloride efflux assays to confirm that 2+ cation-triggered membrane insertion results in the formation of active chloride channels.
RESULTS

Membrane insertion is not driven by oxidation.
CLIC1 has previously been successfully expressed in E. coli, purified and assayed for chloride conductance (1) . To assess if recombinant CLIC1 is able to insert in E. coli membranes, we expressed a C-terminal GFP tagged construct in E. coli and isolated both the cytosolic and membrane fractions. GFP fluorescence measurements for both the soluble fraction and membranes resuspended in similar volumes indicate that the majority of recombinant CLIC1 inserts in the E. coli membrane ( Figure 1A ). CLIC1 is a human protein, but it has been observed to possess chloride efflux activity in mixtures of lipids containing Phosphatidyl Serine (PS) (4) . Given the high proportion of PS lipids in E. coli membranes, it is not surprising that CLIC1 can insert into bacterial membranes.
Oxidation has been proposed as the key trigger for membrane insertion, through the formation of a disulphide bridge between the conserved Cysteine 24 to the non-conserved Cysteine 59, although more recent studies do not reconcile with this mechanism (16, 19 Figure 1B ), indicating that both forms are in the same oxidation state. Reduction of both samples with 5 mM DTT did not cause significant alterations in the spectrum ( Figure S1 ). In contrast, oxidation with H2O2 resulted in large chemical shift differences for a subset of resonances in both spectra, indicating that CLIC1 is inserted in E. coli membranes in the reduced state, and therefore the membrane association process is not triggered by oxidation.
Divalent cations trigger CLIC1 membrane insertion
Since our data indicates that oxidation does not induce membrane insertion, we screened for different conditions that could trigger membrane insertion. A membrane insertion assay was developed, in which CLIC1 was mixed with the lipid mixture asolectin. The mixture was subsequently ultra-centrifuged to separate the soluble and membrane bound components. Native tryptophan fluorescence experiments were collected from the initial mixture, the supernatant and membrane pellets fractions. Using phosphate buffer, which forms insoluble complexes with divalent cations, no insertion could be detected even in the presence of oxidizing conditions. re-localisation to internal membranes and the plasma membrane and a notable decrease of CLIC1 concentration in the cytoplasm, demonstrating the effect of 2+ metal cations on CLIC1 localisation in cells. Together with our previous findings, these images show that metal cations are imperative to CLIC1's mechanism of insertion into the membrane and control of where it is localised.
Dynamics of CLIC1 in solution shows oligomerization in equilibrium.
The formation of the CLIC1 channel has been shown to involve oligomerisation in the membrane to large complexes containing six to eight subunits (20) . In light of this, we explored if CLIC1 oligomerisation also occurs in solution, and if it was modulated by divalent cation binding.
Size exclusion chromatography (SEC) in reducing and not-reducing conditions indicates the presence of at least three species with different molecular weight and some minor high-order oligomers that are not dependent on the formation of disulphide bonds (Figure 4 and S7). To assess the stability of the monomers and oligomers both species was then subjected to a second SEC step.
Again, two peaks were obtained, indicating that CLIC1 exists in a non-covalent equilibrium between the two species ( Figure 4A ). This was confirmed by multiangle light scattering (MALS).
SEC-MALS analysis indicates that the main peaks correspond to monomeric, dimeric and tetrameric species. Treatment with Zn 2+ resulted in strong interactions with the Superdex200 matrix, and no elution peak could be detected.
CLIC1 samples were also subjected to interferometric scattering mass photometry While the structural rearrangements involved in this process are not yet fully understood, the molecular switch between the soluble and membrane bound forms and the changes in oligomerisation state required to generate the chloride channel assembly are now elucidated. This provides a clear mechanism for this unusual and clinically important channel formation process.
METHODS
Protein Expression and Purification
The Human CLIC1 gene (clone HsCD00338210 from the Plasmid service at HMS) was cloned into a pASG vector (IBA) containing an N-terminal twin strep tag and into a pWaldo (26) Chloride Efflux Assays CLIC1 chloride channel activity was assessed using the chloride selective electrode assay described previously (4) . Unilamellar Asolectin vesicles were prepared at 50 mg/mL in 200 mM KCl, 50 mM HEPES (pH 7.4). CLIC1 protein at 11 µM final concentration was mixed with the vesicles, incubated during 5 minutes and then 1 mM Ca(OH)2 or 1 mM ZnSO4 was added to a 2.5 mL final volume mixture and incubated again for 10 minutes. The lipid mixture was then applied to a PD-10 desalting column previously equilibrated in 400 mM Sucrose, 50 mM HEPES (pH 7.4) and collected in 3.5 mL of the same buffer. 500 µL of the lipid mixture were then added to a cup with 4 mL of 400 mM Sucrose, 50 mM HEPES, 10 µM KCl (pH 7.4) and the free chloride concentration was continuously monitored. 60 seconds after the addition of the lipid mix, 10 µM
Valinomycin in ethanol was added and 60 seconds later, 1% TRITON X-100 was also added to release the remaining intra-vesicular chloride.
Fluorescence Microscopy
Giant unilamellar vesicle formation was carried out using a protocol adapted from (29, 30 ). An
Asolectin lipid stock was prepared in 50 mM HEPES, 50 mM NaCl pH 7.4 buffer. 2 µl/cm 2 of 1 mg/ml lipid mixed with 1 mM Nile red lipophilic stain (ACROS Organic) was applied to two ITO slides and dried under vacuum for 2 hours. 100 mM Sucrose, 1 mM HEPES pH 7.4 buffer was used to rehydrate the lipids in the described chamber. 10 Hz frequency sine waves at 1.5 V were applied to the chamber for 2 hours. Liposomes were recovered and diluted into 100 mM glucose, 1 mM HEPES, pH 7.2 buffer. For all four assays 90 nM CLIC1-GFP was incubated with the GUVs with either 0.5 mM ZnCl2, 0.5 mM CaCl2, or were left untreated and incubation at room temperature for ten minutes followed. Microscopy for each assay was performed in an 8 well LabTek Borosilicate Coverglass system (Nun) with a Zeiss LSM-880 confocal microscope using 488 nm and 594 nm lasers. All images were processed with Zen Black software.
HeLa cells were kindly provided by Chris Toseland laboratory, University of Kent. HeLas were maintained in DMEM media supplemented with 10% FBS and 1% Penicillin/Streptomycin at 37°C, 95% humidity and 5% CO2. Etaluma microscope at the same time point as CLIC1 assay cells were fixed. Contrast and brightness were adjusted equally for all images and pseudo colouring was applied for intensity reading, using ImageJ.
Mass Photometry
10µL of the protein/nanodisc was applied to 10 µL buffer on a cover slip resulting in a final concertation of 100nM. The data was collected on a Refeyn OneMP (Refeyn Ltd, UK) mass photometry system. Movies were acquired for 60 seconds. The mass was calculated using a standard protein calibration curve. 
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